Published in Eur Psychiatry on January 06, 2006
Increased incidence and size of cavum septum pellucidum in children with chromosome 22q11.2 deletion syndrome. Psychiatry Res (2010) 0.85
Volumetric analysis of septal region in schizophrenia and affective disorder. Eur Arch Psychiatry Clin Neurosci (2006) 0.82
Microstructural thalamic changes in schizophrenia: a combined anatomic and diffusion weighted magnetic resonance imaging study. J Psychiatry Neurosci (2008) 0.81
Cavum septum pellucidum in patients with first episode psychosis and individuals at high risk of psychosis. Eur Psychiatry (2007) 0.76
Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness. Neuroimage Clin (2016) 0.75
Prevalence and Characteristics of Cavum Septum Pellucidum in Schizophrenia: A 16 Slice Computed Tomography Study. Indian J Psychol Med (2016) 0.75
A magnetic resonance imaging study of adhesio interthalamica in clinical subtypes of schizophrenia. Indian J Psychiatry (2013) 0.75
Midline Brain Abnormalities Across Psychotic and Mood Disorders. Schizophr Bull (2015) 0.75
The double massa intermedia. Surg Neurol Int (2016) 0.75
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations. Neurosci Biobehav Rev (2007) 2.25
Diffusion tensor imaging in schizophrenia. Biol Psychiatry (2005) 2.14
[Brain effects of cannabis--neuroimaging findings]. Rev Bras Psiquiatr (2005) 2.05
Temporal course of auditory hallucinations. Br J Psychiatry (2004) 1.95
White matter integrity and cognitive impairment in first-episode psychosis. Am J Psychiatry (2010) 1.92
Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry (2006) 1.81
Tract-specific anisotropy measurements in diffusion tensor imaging. Psychiatry Res (2005) 1.79
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry (2013) 1.76
The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol (2004) 1.76
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry (2009) 1.69
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology (2009) 1.62
Neural systems underlying British Sign Language and audio-visual English processing in native users. Brain (2002) 1.60
Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull (2012) 1.58
Resting-state functional connectivity in normal brain aging. Neurosci Biobehav Rev (2013) 1.55
Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain (2006) 1.54
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry (2010) 1.52
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol Psychiatry (2009) 1.49
Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine (2011) 1.48
Psychometric properties of the Fagerström Test for Nicotine Dependence. J Bras Pneumol (2009) 1.46
Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiol Aging (2009) 1.46
Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res (2008) 1.43
X-linked adrenoleukodystrophy in heterozygous female patients: women are not just carriers. Arq Neuropsiquiatr (2012) 1.42
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology (2011) 1.41
Duloxetine in the treatment of social anxiety disorder. J Clin Psychopharmacol (2007) 1.40
Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol (2009) 1.40
Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch Gen Psychiatry (2004) 1.36
The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35
Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. BMC Psychiatry (2011) 1.34
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32
Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp (2009) 1.32
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol (2010) 1.31
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl (2007) 1.31
Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry (2005) 1.30
Acoustic noise and functional magnetic resonance imaging: current strategies and future prospects. J Magn Reson Imaging (2002) 1.29
Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry (2012) 1.29
Alterations in white matter evident before the onset of psychosis. Schizophr Bull (2012) 1.29
White matter microstructure underlying default mode network connectivity in the human brain. Neuroimage (2009) 1.29
Neural correlates of executive function and working memory in the 'at-risk mental state'. Br J Psychiatry (2009) 1.29
Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol (2005) 1.27
Dissociating linguistic and nonlinguistic gestural communication in the brain. Neuroimage (2004) 1.24
Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry (2008) 1.24
What causes the onset of psychosis? Schizophr Res (2005) 1.24
Use of SVM methods with surface-based cortical and volumetric subcortical measurements to detect Alzheimer's disease. J Alzheimers Dis (2010) 1.23
An fMRI study of verbal self-monitoring: neural correlates of auditory verbal feedback. Cereb Cortex (2005) 1.22
The very preterm brain in young adulthood: the neural correlates of verbal paired associate learning. J Pediatr (2010) 1.22
Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT. J Neuroimaging (2005) 1.20
Misattribution of speech and impaired connectivity in patients with auditory verbal hallucinations. Hum Brain Mapp (2007) 1.20
Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology (2012) 1.19
The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain (2003) 1.19
Inner speech models of auditory verbal hallucinations: evidence from behavioural and neuroimaging studies. Int Rev Psychiatry (2007) 1.17
Meditation training increases brain efficiency in an attention task. Neuroimage (2011) 1.17
Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br J Psychiatry Suppl (2007) 1.16
White matter defects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging. Neuroimage (2009) 1.15
Neuroanatomy of auditory verbal hallucinations in schizophrenia: a quantitative meta-analysis of voxel-based morphometry studies. Cortex (2012) 1.14
Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Psychiatry Res (2006) 1.13
Fronto-temporal interactions during overt verbal initiation and suppression. J Cogn Neurosci (2008) 1.13
Multisite fMRI reproducibility of a motor task using identical MR systems. J Magn Reson Imaging (2007) 1.11
Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication. JAMA Psychiatry (2013) 1.11
Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry. Eur Arch Psychiatry Clin Neurosci (2004) 1.11
Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Res (2008) 1.11
Age-related gray matter volume changes in the brain during non-elderly adulthood. Neurobiol Aging (2009) 1.10
A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: greater anterior cingulate activation with increased task demand. Neuroimage (2002) 1.10
State-dependent microstructural white matter changes in bipolar I depression. Eur Arch Psychiatry Clin Neurosci (2009) 1.10
Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology (2004) 1.10
Neural correlates of British sign language comprehension: spatial processing demands of topographic language. J Cogn Neurosci (2002) 1.09
White matter volume changes in people who develop psychosis. Br J Psychiatry (2008) 1.09
Reduced cortical folding in schizophrenia: an MRI morphometric study. Am J Psychiatry (2003) 1.08
Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry (2005) 1.08
Engagement of brain areas implicated in processing inner speech in people with auditory hallucinations. Br J Psychiatry (2003) 1.08
Cannabidiol monotherapy for treatment-resistant schizophrenia. J Psychopharmacol (2006) 1.08
Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res (2006) 1.07
Virtual reality and paranoid ideations in people with an 'at-risk mental state' for psychosis. Br J Psychiatry Suppl (2007) 1.07
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry (2012) 1.07
Brain response to visceral aversive conditioning: a functional magnetic resonance imaging study. Gastroenterology (2005) 1.07
Gender differences in white matter microstructure. PLoS One (2012) 1.07
Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull (2011) 1.07
Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers. Biol Psychiatry (2003) 1.06
The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. Brain (2004) 1.06
Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry (2014) 1.05
Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency. Am J Psychiatry (2005) 1.05
Neural correlates of the misattribution of speech in schizophrenia. Br J Psychiatry (2007) 1.04